Joshua Dennerlein
Stock Analyst at B of A Securities
(2.32)
# 2,350
Out of 4,818 analysts
90
Total ratings
45.9%
Success rate
-4.79%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $533.41 | +9.67% | 1 | Apr 10, 2025 | |
| WELL Welltower | Maintains: Buy | $221 → $242 | $147.83 | +63.70% | 7 | Feb 18, 2025 | |
| SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $122.25 | -6.75% | 2 | Nov 12, 2024 | |
| FVR FrontView REIT | Initiates: Buy | $22 | $12.16 | +80.92% | 1 | Oct 28, 2024 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $28.51 | +19.26% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $30.41 | +1.94% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $75.52 | +21.82% | 1 | Sep 24, 2024 | |
| ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $277.09 | +15.85% | 3 | Sep 24, 2024 | |
| LINE Lineage | Initiates: Buy | $100 | $56.50 | +76.99% | 1 | Aug 19, 2024 | |
| CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $114.04 | +28.90% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $159.81 | +18.27% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $49.29 | -18.85% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $18.82 | +32.84% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $37.99 | -18.40% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $68.64 | -22.79% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $6.46 | -7.05% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $41.88 | -21.20% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $16.02 | -6.37% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $58.03 | -10.38% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.62 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $61.07 | -11.58% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $5.33 | +50.09% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $12.43 | +117.22% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $20.18 | +66.01% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.10 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $77.19 | +1.06% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $41.10 | +14.37% | 2 | Jan 20, 2022 |
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $533.41
Upside: +9.67%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $147.83
Upside: +63.70%
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $122.25
Upside: -6.75%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $12.16
Upside: +80.92%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $28.51
Upside: +19.26%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $30.41
Upside: +1.94%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $75.52
Upside: +21.82%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $277.09
Upside: +15.85%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $56.50
Upside: +76.99%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $114.04
Upside: +28.90%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $159.81
Upside: +18.27%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $49.29
Upside: -18.85%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $18.82
Upside: +32.84%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $37.99
Upside: -18.40%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $68.64
Upside: -22.79%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $6.46
Upside: -7.05%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $41.88
Upside: -21.20%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $16.02
Upside: -6.37%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $58.03
Upside: -10.38%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $17.62
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $61.07
Upside: -11.58%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $5.33
Upside: +50.09%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $12.43
Upside: +117.22%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $20.18
Upside: +66.01%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.10
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $77.19
Upside: +1.06%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $41.10
Upside: +14.37%